← back to search

Mario Witkowski

Leibniz Association ·
Area of research
Infectious Diseases · Immunology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, IL-33, ST2, and ILC Pathways, COVID-19 Clinical Research Studies, and Blood Coagulation and Thrombosis Mechanisms.
h-index
16
citations
1,716
works
30
NIH funding
primary concept
email

Recent publications

TGFβ links EBV to multisystem inflammatory syndrome in children
Nature 2025cited by 28position: middledoi
A transcriptional atlas of gut-innervating neurons reveals activation of interferon signaling and ferroptosis during intestinal inflammation
Neuron 2025cited by 14position: middledoi
IL-1R1-positive dorsal raphe neurons drive self-imposed social withdrawal in sickness
Cell 2025cited by 10position: middledoi
Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow
Nature Communications 2024cited by 20position: middledoi
Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells
Nature Communications 2024cited by 10position: middledoi
Cross-regulation of antibody responses against the SARS-CoV-2 Spike protein and commensal microbiota via molecular mimicry
Cell Host & Microbe 2023cited by 18position: middledoi
Serum TGF‐β as a predictive biomarker for severe disease and fatality of COVID‐19
European Journal of Immunology 2023cited by 15position: middledoi
Untimely TGFβ responses in COVID-19 limit antiviral functions of NK cells
Nature 2021cited by 279position: firstdoi
SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
Nature Communications 2021cited by 224position: middledoi
Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues
Immunity 2020cited by 81position: middledoi
Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes
Cardiovascular Diabetology 2020cited by 52position: middledoi
IL22BP Mediates the Antitumor Effects of Lymphotoxin Against Colorectal Tumors in Mice and Humans
Gastroenterology 2020cited by 42position: middledoi
Interleukin-22 protects intestinal stem cells against genotoxic stress
Nature 2019cited by 356position: middledoi
Recipe for IBD: can we use food to control inflammatory bowel disease?
Seminars in Immunopathology 2017cited by 39position: firstdoi
A pathogenic role for T cell–derived IL-22BP in inflammatory bowel disease
Science 2016cited by 135position: middledoi
Micro–RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor
Arteriosclerosis Thrombosis and Vascular Biology 2016cited by 80position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Caroline Tizian · Humboldt-Universität zu Berlin3 papers (2019–2024)Marco Witkowski · Franklin University3 papers (2016–2020)Pawel Durek · German Centre for Cardiovascular Research3 papers (2020–2024)Mir‐Farzin Mashreghi · German Rheumatism Research Centre3 papers (2020–2024)Konrad Gronke · Roche (Switzerland)2 papers (2019–2020)Andrey Kruglov · University of Alabama at Birmingham2 papers (2020–2024)Ulf Landmesser · Intensive Care Foundation2 papers (2016–2020)Ursula Rauch · Humboldt-Universität zu Berlin2 papers (2016–2020)Termeh Tabaraie · Johannes Gutenberg University Mainz2 papers (2016–2020)Michael Kofoed-Branzk · Humboldt-Universität zu Berlin2 papers (2019–2020)Samuel Huber · Universität Hamburg2 papers (2016–2017)Patrycja M. Forster · Humboldt-Universität zu Berlin2 papers (2024–2025)Andreas Diefenbach · German Center for Lung Research2 papers (2019–2020)Diethelm Tschoepe · Johannes Gutenberg University Mainz2 papers (2016–2020)Christoph S. N. Klose · Humboldt-Universität zu Berlin2 papers (2019–2024)Manuel O. Jakob · University Hospital of Bern2 papers (2024–2025)Nicola Gagliani · Universität Hamburg2 papers (2016–2017)Bernd Stratmann · Johannes Gutenberg University Mainz2 papers (2016–2020)Fabian Guendel · Inserm2 papers (2019–2020)Aritra Chakraborty · Charité - Universitätsmedizin Berlin1 papers (2020–2020)